Central Government issues Guidelines for Scheme to Strengthen Pharmaceuticals Industry (SPI); aims to strengthen existing infrastructure facilities to improve productivity, quality and sustainability by Anum Ahmed | Apr 12, 2022 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022 by Lexplosion | Mar 25, 2022 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017 by Anum Ahmed | Aug 27, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority by Lexplosion | Aug 9, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021 by Lexplosion | Aug 5, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Department of Commerce restricts the export of Remdesivir Injection & Remdesivir Active Pharmaceutical Ingredients (API) ; no separate export authorization will be required by Anum Ahmed | Jun 17, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More